RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Antithrombin Therapy for ACS: Heparin, Enoxaparin, and Bivalirudin
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 4
SP 28
OP 29
DO 10.1177/155989771204019
UL http://mdc.sagepub.com/content/12/4/28.abstract
AB Effective adjunctive treatment of acute coronary syndrome with antithrombin therapy is essential to reduce ischemic complications, and researchers continue to compare novel antithrombotic agents with currently available ones in an effort to optimize outcomes. These comparisons require careful evaluation of the benefit-risk balance, with a primary consideration of reduction of ischemic complications weighed against bleeding risk.